Table 4

Quality assurance for screening mammography programmes represented in the International Breast Cancer Screening Network: Outcome Components, 1998

		% Population screened				Monitor/assess
		Set goal	Monitor goal			Technical recall	Set maximum recall^4-150	Follow up care	Adverse events	Client satisfaction	Cancer detection rate	Programme improvement
National programmes
Australia	Yes	Yes		Yes	Yes (3%)	Yes	Yes	Yes^4-1	Yes	Yes
Finland	No	—		No	—	Yes	Yes	Yes	Yes	Yes
Iceland	Yes	Yes		No	—	Yes	No	Yes	Yes	Yes
Israel	Yes	Yes		No	—	Yes	Yes	Yes	Yes	Yes^4-1
Luxembourg	Yes	Yes		Yes	No	Yes	Yes	Yes	Can be	Yes
Netherlands	Yes	Yes		Yes	No	Yes	Yes	Yes	Yes	Yes^4-1
United Kingdom	Yes	Yes		Yes	Yes (3%)	Yes	Yes	Yes^4-1	Yes	Yes^4-1
State, provincial, local programmes
Established
Belgium	Yes	No		No	—	Yes	Yes	Yes	Can be	Yes
Canada^4-152	Yes	Yes		Yes	Yes (2–5%)	No	No	Yes	Yes	Yes^4-1
Denmark	No	—		Yes	No	Yes	Yes	Yes^4-1	Yes	Yes^4-1
France^4-152	Yes	Yes		Yes	Yes (2%)	Yes	Yes	Yes	Yes	Yes
Italy^4-152	Yes	Yes		Yes	No	Yes	Yes	Yes	Yes	Yes
Norway	Yes	Yes		Yes	Yes (2%)	Yes	Yes	Yes	Yes	Yes^4-1
Portugal	No	—		Yes	Yes (1%)	Yes	Yes	Yes	Yes	Yes^4-1
Spain	Yes	Yes		Yes	No	Yes	No	Yes	Yes	Yes^4-1
Sweden^4-152	Yes	Yes		Yes	No	Yes	Yes	Yes	Yes	Yes
Pilot
Germany^4-151	Yes	Yes		Yes	Yes (3–5%)	Yes	Yes	Yes^4-1	Yes	Yes^4-1
Greece	Yes	Yes		Yes	Yes (3%)	Yes	Yes	Yes^4-1	Yes	Yes^4-1
Hungary	Yes	Yes		Yes	Yes (5%)	Yes	Yes	No	Yes	Yes
Japan	Yes	Yes		No	—	Yes	No	No	Yes	No
Uruguay	No	—		Yes	No	Yes	No	Yes	Yes	Yes^4-1
Registry programme
United States^4-2	Yes	Yes		Yes	No	Yes^4-3	Yes^4-3	Yes^4-1	Yes	Yes

↵4-150 For technical reasons.
↵4-1 Routinely.
↵4-2 The Mammography Quality Standards Act (MQSA) requires all mammography facilities to conduct medical outcomes audits, in which mammography results are systematically collected and compared with outcomes data. Individual facilities determine which outcomes to examine.
↵4-3 Required of all mammography facilities in the US under the Mammography Quality Standards Act (MQSA).
↵4-151 Denotes programme in implementation.
↵4-152 Denotes countries with a decentralised (subnational) organisation of screening mammography, but in which the totality of organised screening programmes attains national coverage.